Planning

Sprionaloctone

NHS ENGLAND, LEEDS

This public procurement record has 1 release in its history.

Planning

26 Feb 2025 at 16:07

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS England, based in Leeds, is currently in the planning stage of a procurement process for a project titled "Spironolactone". This planning involves a Preliminary Market Engagement Notice for a licence variation concerning spironolactone use for acne in women. The relevant industry category is health services, and the project is set to take place primarily in Leeds, United Kingdom. Key milestones include the availability of the Request for Information (RFI) from 25 February 2025 and the deadline for responses and 1:1 meetings by 12:00 noon on 11 March 2025. The procurement method follows engagement with the market, allowing for supplier feedback and discussions before tendering takes place.

This tender offers considerable opportunities for businesses specialising in healthcare and pharmaceutical services, particularly those with expertise in marketing authorisations. Specifically, there are two contracts available: one for preparing an application for a type II major MHRA Marketing Authorisation variation and another for submitting a pre-prepared application to the MHRA. The tender is suited for current Marketing Authorisation Holders of spironolactone, with potential for significant business growth derived from successful partnership with NHS England in delivering these critical health services. Small and medium-sized enterprises (SMEs) with relevant experience are encouraged to engage in this market exercise.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Sprionaloctone

Notice Description

NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. * Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. * Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B. To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis.

Planning Information

NHS England would like to gather soft intelligence from the market and is publishing a Request for Information for the two contracts. NHS England would also be pleased to offer 1:1 meetings with potential Suppliers to discuss this innovative partnership approach. The Request for Information and further documentation will be available from 25 February 2025 and the deadline for responses and 1:1 meetings will be 12 noon on 11 March 2025.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04e834
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/007330-2025
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
26 Feb 202512 months ago
Submission Deadline
Not specified
Future Notice Date
1 May 2025Expired
Award Date
Not specified
Contract Period
1 Sep 2025 - 30 Jun 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND, LEEDS
Contact Name
Leigh Parker
Contact Email
leigh.parker1@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Post Town
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-04e834-2025-02-26T16:07:07Z",
    "date": "2025-02-26T16:07:07Z",
    "ocid": "ocds-h6vhtk-04e834",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PDPT-3135-BWWY",
            "name": "NHS England, Leeds",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PDPT-3135-BWWY"
            },
            "address": {
                "streetAddress": "7&8 Wellington Place",
                "locality": "Leeds",
                "postalCode": "LS1 4AP",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKE42"
            },
            "contactPoint": {
                "name": "Leigh Parker",
                "email": "leigh.parker1@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PDPT-3135-BWWY",
        "name": "NHS England, Leeds"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "NHS England would like to gather soft intelligence from the market and is publishing a Request for Information for the two contracts. NHS England would also be pleased to offer 1:1 meetings with potential Suppliers to discuss this innovative partnership approach. The Request for Information and further documentation will be available from 25 February 2025 and the deadline for responses and 1:1 meetings will be 12 noon on 11 March 2025.",
                "dueDate": "2025-03-14T23:59:59Z",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "007330-2025",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/007330-2025",
                "datePublished": "2025-02-26T16:07:07Z",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "C341339",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Sprionaloctone",
        "description": "NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. * Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. * Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B. To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 0,
            "amount": 0,
            "currency": "GBP"
        },
        "mainProcurementCategory": "services",
        "aboveThreshold": true,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2025-09-01T00:00:00Z",
                    "endDate": "2027-06-30T23:59:59Z"
                },
                "status": "planning"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-05-01T23:59:59Z"
        },
        "status": "planning"
    },
    "language": "en"
}